KRN Labs is proud to announce the release of SurgicaVR ProHaptics, a cutting-edge virtual reality surgical simulator that offers the most advanced haptic force feedback technology available on the market. The simulator integrates Follou’s Haptic Avatar – the newest haptic laparoscopic interface, which provides the most precise force-feedback in all possible degrees of freedom.
The high-fidelity haptic force feedback technology in SurgicaVR ProHaptics allows medical professionals to train in laparoscopic procedures with unparalleled realism. The simulation software is based on years of experience of KRN’s in surgical simulation software development. The haptic feedback enables the user to feel the resistance and haptic feedback of the surgery, which allows for a more realistic and accurate training experience.
“We are excited to introduce SurgicaVR ProHaptics to the medical community,” said Dr Przemysław Korzeniowski, CEO of KRN Labs. “It provides an unprecedented level of realism and immersion, allowing surgeons to train and improve their skills in a safe and controlled environment. The simulator allows for a more realistic and accurate training experience, which is especially important for training in complex laparoscopic procedures.”
SurgicaVR ProHaptics had its world premiere at ArabHealth 2023 in Dubai and is now available for purchase. It offers a cost-effective solution for surgical training, allowing medical institutions to provide their staff with the highest quality training available.
“We are excited to have SurgicaVR ProHaptics as part of our product offering. We believe that the high-fidelity haptic force feedback technology will revolutionize surgical training,” said Dr Korzeniowski.
KRN Labs is committed to providing medical professionals with the highest quality training tools, and SurgicaVR ProHaptics is the latest addition to our portfolio. We invite all medical institutions and surgeons to try SurgicaVR ProHaptics and experience the benefits of this revolutionary virtual reality surgical simulator.